RUBIN PAUL D
Chief Medical Officer · 16 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-04-01 | BIOA | BioAge Labs, Inc. | Sale | 8,820 | $17.81 | $157,084.20 | filing |
| 2026-04-01 | BIOA | BioAge Labs, Inc. | Option exercise | 5,437 | $4.11 | $22,346.07 | filing |
| 2026-04-01 | BIOA | BioAge Labs, Inc. | Option exercise | 3,383 | $6.57 | $22,226.31 | filing |
| 2026-03-02 | BIOA | BioAge Labs, Inc. | Sale | 7,433 | $20.30 | $150,889.90 | filing |
| 2026-03-02 | BIOA | BioAge Labs, Inc. | Option exercise | 5,433 | $4.11 | $22,329.63 | filing |
| 2026-03-02 | BIOA | BioAge Labs, Inc. | Option exercise | 2,000 | $6.57 | $13,140.00 | filing |
| 2026-02-02 | BIOA | BioAge Labs, Inc. | Sale | 7,433 | $18.75 | $139,368.75 | filing |
| 2026-02-02 | BIOA | BioAge Labs, Inc. | Option exercise | 5,433 | $4.11 | $22,329.63 | filing |
| 2026-02-02 | BIOA | BioAge Labs, Inc. | Option exercise | 2,000 | $6.57 | $13,140.00 | filing |
| 2026-01-02 | BIOA | BioAge Labs, Inc. | Sale | 7,433 | $12.85 | $95,490.26 | filing |
| 2026-01-02 | BIOA | BioAge Labs, Inc. | Option exercise | 5,433 | $4.11 | $22,329.63 | filing |
| 2026-01-02 | BIOA | BioAge Labs, Inc. | Option exercise | 2,000 | $6.57 | $13,140.00 | filing |
| 2025-12-09 | BIOA | BioAge Labs, Inc. | Sale | 18,000 | $12.00 | $216,000.00 | filing |
| 2025-12-09 | BIOA | BioAge Labs, Inc. | Option exercise | 18,000 | $6.57 | $118,260.00 | filing |
| 2025-12-04 | BIOA | BioAge Labs, Inc. | Sale | 68,897 | $10.19 | $701,908.86 | filing |
| 2025-12-04 | BIOA | BioAge Labs, Inc. | Option exercise | 68,897 | $4.11 | $283,166.67 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.